Skip to content
Screener

Enovis ENOV EPS (Basic)

EPS (Basic) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.300.0%
Stryker logo
StrykerSYK
$3.32+43.1%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$0.39-8.3%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$1.03+33.8%
Treace Medical Concepts, Inc. logo
Treace Medical Concepts, Inc.TMCI
-$0.24+14.3%
ESAB logo
ESABESAB
$0.50-54.5%

Other financials

Income statement

See full
Revenue$582.8M+3.2%
Gross profit$359.2M+7.3%
Operating income$17.4M+204%
Net income-$1.2M+96.8%
EPS (diluted)-$0.02+96.9%

Balance sheet

See full
Cash & equivalents$12.6M-71.5%
Total debt$1.3B-6.4%
Total equity$1.5B-42.7%
Total assets$3.8B-25.0%

Cash flow

See full
Operating cash flow$75.0M+57.1%
CapEx$43.9M-1.1%
Free cash flow$31.1M

Valuation

See full
Market cap$1.52B+3.1%
Enterprise value$2.81B-0.4%
P/S0.7×0.0×

Profitability

See full
Gross margin61.1%+3.5pp
Operating margin-45.1%+19.4pp
Net margin-48%+17.7pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-54.3%+672pp
Debt / equity0.9×+0.3×
Current ratio-0.3×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The source filing: Enovis’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:45 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001420800-26-000035
Line itemThree Months Ended / July 3, 2026Three Months Ended / July 4, 2025Six Months Ended / July 3, 2026Six Months Ended / July 4, 2025
Net loss from continuing operations(1,036)(36,455)(9,447)(92,035)
Loss from discontinued operations, net of taxes(93)(39)(218)
Net loss(1,036)(36,548)(9,486)(92,253)
Less: net income attributable to noncontrolling interest from continuing operations - net of taxes154191468452
Net loss attributable to Enovis Corporation$(1,190)$(36,739)$(9,954)$(92,705)
Net income (loss) per share - basic and diluted
Continuing operations$(0.02)$(0.64)$(0.17)$(1.62)
Consolidated operations$(0.02)$(0.64)$(0.17)$(1.62)

Item 1. Financial Statements

FAQ

What is Enovis's EPS (basic)?
Enovis (ENOV) reported EPS (basic) of -$0.02 in Q2 2026.
How has Enovis's EPS (basic) changed year-over-year?
Enovis's EPS (basic) increased by 96.9% year-over-year, from -$0.64 to -$0.02.
What is the long-term trend for Enovis's EPS (basic)?
Over 4 years (2021 to 2025), Enovis's EPS (basic) has grown at a 95.4% compound annual growth rate (CAGR), from $1.42 to -$20.72.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.

Ask your AI about Enovis's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude